trending Market Intelligence /marketintelligence/en/news-insights/trending/BlnhY9QDXca36cyCVnwlLA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Arcturus Therapeutics to raise $10.9M in registered direct offering

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Arcturus Therapeutics to raise $10.9M in registered direct offering

Arcturus Therapeutics Holdings Inc. started a registered direct offering of common shares to raise about $10.9 million in gross proceeds.

The San Diego-based biotechnology company, which develops therapies for liver and respiratory diseases, will sell 945,653 common shares to certain institutional investors at $11.50 apiece.

Arcturus plans to use the proceeds for its research and development activities and general corporate purposes.

The company expects to close the offering by Aug. 5, subject to closing conditions.

H.C. Wainwright & Co. is the exclusive placement agent for the offering.